ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $6,862,000 | +0.8% | 8,000,000 | 0.0% | 0.05% | -5.6% |
| Q1 2017 | $6,808,000 | +19923.5% | 8,000,000 | +17677.8% | 0.05% | – |
| Q4 2016 | $34,000 | -99.5% | 45,000 | -99.5% | 0.00% | -100.0% |
| Q3 2016 | $6,946,000 | -6.4% | 8,436,000 | 0.0% | 0.05% | -3.8% |
| Q2 2016 | $7,418,000 | -55.2% | 8,436,000 | -54.4% | 0.05% | -52.7% |
| Q1 2016 | $16,557,000 | -60.8% | 18,506,000 | -49.2% | 0.11% | -59.0% |
| Q4 2015 | $42,250,000 | +21.7% | 36,450,000 | -4.1% | 0.27% | +12.1% |
| Q3 2015 | $34,711,000 | -9.4% | 38,013,000 | +0.4% | 0.24% | +0.8% |
| Q2 2015 | $38,293,000 | +4.4% | 37,870,000 | +5.3% | 0.24% | +3.0% |
| Q1 2015 | $36,692,000 | +29.3% | 35,956,000 | +46.0% | 0.23% | +22.3% |
| Q4 2014 | $28,371,000 | +39.9% | 24,621,000 | +25.6% | 0.19% | +39.3% |
| Q3 2014 | $20,273,000 | – | 19,596,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYMPHONY ASSET MANAGEMENT LLC | 23,872,000 | $18,748,000 | 4.04% |
| PFM Health Sciences, LP | 49,764,825 | $39,319,000 | 1.16% |
| Partner Investment Management, L.P. | 659,175 | $521,000 | 0.89% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 40,000,000 | $31,402,000,000 | 0.87% |
| Bruce & Co., Inc. | 6,000,000 | $4,200,000 | 0.87% |
| CANYON CAPITAL ADVISORS LLC | 36,500,000 | $28,747,000 | 0.62% |
| PenderFund Capital Management Ltd. | 2,000,000 | $1,571,000 | 0.53% |
| Shaolin Capital Management LLC | 4,000,000 | $3,136,000 | 0.48% |
| Castle Creek Arbitrage, LLC | 2,310,000 | $1,815,000 | 0.46% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,500,000 | $4,368,000 | 0.27% |